Literature DB >> 15597674

Histoplasmosis in Africa: a review.

H C Gugnani1.   

Abstract

Classical histoplasmosis caused by Histoplasma capsulatum var. capsulatum, and African histoplasmosis caused by H. capsulatum var. duboisii are both endemic in Africa. In South Africa, only classical histoplasmosis caused by Histoplasma capsulatum var. capsulatum is known to occur and cases are seen frequently. It occurs sporadically in several other African countries. Histoplasma capsulatum var. capsulatum is known to occur naturally in caves inhabited by bats in some parts of South Africa, namely, Transvaal and Cape province, Zimbabwe and Tanzania. Outbreaks of histoplasmosis have been reported in cave explorers. Surveys of histoplasmin skin sensitivity carried out in Africa have shown the rate of positive reactors to be from 0.0% to 28%. African histoplasmosis caused by H. capsulatum var. duboisii is prevalent in Western and Central Africa, and in the island of Madagascar between the Kalahari and Sahara deserts, that is between latitudes 20 degrees North and 20 degrees South of the Equator. A natural reservoir of this fungus in soil admixed with bat guano has been found in a bat cave in a rural area, viz. Ogbunike in Anambra State of Nigeria. The clinical features and epidemiology of the two forms of the disease in Africa are reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 15597674

Source DB:  PubMed          Journal:  Indian J Chest Dis Allied Sci        ISSN: 0377-9343


  16 in total

1.  A traveller in time: Phylogenetic analysis to identify a disseminated infection acquired 30 years earlier.

Authors:  William Ciccotelli; Shariq Haider; Jianping Xu
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-07       Impact factor: 2.471

2.  Amplification of blood smear DNA to confirm disseminated histoplasmosis.

Authors:  T Dieng; A Massaly; D Sow; S Vellaissamy; K Sylla; R C Tine; Y Dieng; C Hennequin
Journal:  Infection       Date:  2017-02-18       Impact factor: 3.553

3.  Imported African histoplasmosis in an immunocompetent patient 40 years after staying in a disease-endemic area.

Authors:  Clémence Richaud; Marie-Olivia Chandesris; Fanny Lanternier; Hélène Benzaquen-Forner; Dea Garcia-Hermoso; Capucine Picard; Emilie Catherinot; Marie-Elisabeth Bougnoux; Olivier Lortholary
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

4.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

Review 5.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Gingival histoplasmosis: An atypical presentation of African histoplasmosis in three baboons (Papio spp).

Authors:  Taylor A Johannigman; Olga Gonzalez; John W Dutton; Shyamesh Kumar; Edward J Dick
Journal:  J Med Primatol       Date:  2019-10-08       Impact factor: 0.667

7.  Disseminated histoplasmosis by Histoplasma capsulatum var. duboisii in a paediatric patient from the Chad Republic, Africa.

Authors:  A Garcia-Guiñon; J M Torres-Rodríguez; D Torangar Ndidongarte; F Cortadellas; L Labrín
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-13       Impact factor: 3.267

8.  Disseminated cutaneous histoplasmosis in an immunocompetent adult.

Authors:  Manoj Harnalikar; Vidya Kharkar; Uday Khopkar
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

Review 9.  An unusual cutaneous tumor: African histoplasmosis following mudbaths: case report and review.

Authors:  Sotirios Tsiodras; Miranda Drogari-Apiranthitou; Konstantinos Pilichos; Konstantinos Leventakos; Theodoros Kelesidis; Maria Jose Buitrago; Georgios Petrikkos; Ioannis Panayiotides
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 3.707

Review 10.  Meningitis in HIV-positive patients in sub-Saharan Africa: a review.

Authors:  Jennifer A Veltman; Claire C Bristow; Jeffrey D Klausner
Journal:  J Int AIDS Soc       Date:  2014-10-10       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.